Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,276.60 -110.97 -0.72%
S&P 500 1,653.12 -16.04 -0.96%
Nasdaq 3,448.38 -53.74 -1.53%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

232.0000 USD 0.6700 0.29%

As of 15:27:35 ET on 05/22/2013.

Snapshot for Biogen Idec Inc (BIIB)

Open: 232.2700 Day's Range: 230.0600 - 238.8300 Volume: 1,113,462
Previous Close: 231.3300 52wk Range: 126.3900 - 238.8300 1-Yr Rtn: +75.32%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 232.0300
  • 1D
  • 1M
  • 1Y
231.3300
Interactive BIIB Chart

Previous Close

Key Statistics for BIIB

Current P/E Ratio (ttm) 37.7530
Estimated P/E(12/2013) 29.6189
Relative P/E vs. SPX 2.2813
Earnings Per Share (USD) (ttm) 6.2379
Est. EPS (USD) (12/2013) 7.9510
Est. PEG Ratio 1.5881
Market Cap (M USD) 55,901.77
Shares Outstanding (M) 237.37
30 Day Average Volume 1,371,799
Price/Book (mrq) 7.5039
Price/Sale (ttm) 9.7591
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

William D Young "Bill"Non-Executive ChairmanGeorge A ScangosChief Executive Officer
Susan H AlexanderExec VP/Chief Legal Ofcr/SecyPaul J ClancyExec VP:Finance/CFO
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil